BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2009
View Archived Issues
Phase I results position cancer vaccines MKC-1106 PP and MKC-1106 MT for phase II
Read More
Carboplatin-docetaxel combination beneficial in hormone-refractory prostate cancer
Read More
Novel compounds with preclinical antinociceptive activity disclosed by Abbott
Read More
Hematide is safe and increases Hb levels in CKD patients on hemodialysis
Read More
PBI-1402 shows renoprotective effects in mouse model of acute nephrotoxicity
Read More
Rosuvastatin reduces cardiac events in diabetic patients with ESRD
Read More
Preclinical data show potential of ALN-TTR for the treatment of ATTR / News in Context
Read More
Ironwood and Astellas sign licensing agreement for linaclotide in Japan and other territories
Read More
Cytokinetics presents update on phase I trials of CK-2017357
Read More
Evidence of genetic impact on response to LY-2140023 found
Read More
Sanofi-aventis and Regeneron expand collaboration for monoclonal antibodies
Read More
Phase IIa trial of Novavax's seasonal influenza vaccine in older adults under way
Read More
GSK begins largest malaria vaccine phase III trial in 7 African countries
Read More
GSK and Pfizer launch specialist HIV company ViiV Healthcare
Read More
Cytos Biotechnology updates the development of its hypertension vaccine
Read More
Cytopia and YM BioSciences amend terms of merger agreement
Read More
Novel antineoplastic agents claimed by Gilead
Read More
Urotensin II receptor antagonists in early development at sanofi-aventis
Read More
Concert Pharmaceuticals claims novel NDRIs for the treatment of depression
Read More
AMT reports results from preclinical study of gene therapy for DMD
Read More
Aastrom to initiate U.S. phase II clinical trial of catheter delivery of CRCs for DCM
Read More
New safety data supports continuation of Affymax's phase III program for Hematide
Read More
TapImmune and Crucell sign license agreement for PER.C6 cells in vaccine development
Read More
FDA approves CSL Biotherapies' application for accelerated approval of Afluria in children
Read More
TGA requests additional data from Acrux prior to marketing approval of Ellavie
Read More